ArticlePloS one2015

The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma.

Xiaoxiao Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.